SECIX
Price
$47.57
Change
-$0.08 (-0.17%)
Updated
Sep 8 closing price
Net Assets
70.22M
VIVAX
Price
$71.08
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

SECIX vs VIVAX

Header iconSECIX vs VIVAX Comparison
Open Charts SECIX vs VIVAXBanner chart's image
NAA Large Cap Value A
Price$47.57
Change-$0.08 (-0.17%)
VolumeN/A
Net Assets70.22M
Vanguard Value Index I
Price$71.08
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
SECIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SECIX vs. VIVAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SECIX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. SECIX (70.2M). VIVAX pays higher dividends than SECIX: VIVAX (1.99) vs SECIX (1.22). SECIX was incepted earlier than VIVAX: SECIX (81 years) vs VIVAX (33 years). SECIX (1.37) is less costly to investors than VIVAX (0.17). SECIX is a more actively managed with annual turnover of: 13.00 vs. VIVAX (9.00). SECIX has a lower initial minimum investment than VIVAX: SECIX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 7.74 vs. SECIX (-1.02). VIVAX return over 5 years is better than : 70.18 vs. SECIX (30.72).
SECIXVIVAXSECIX / VIVAX
Total Expense Ratio1.100.17647%
Annual Report Gross Expense Ratio1.370.17806%
Fund Existence81 years33 years-
Gain YTD8.0997.845103%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets70.2M203B0%
Annual Yield % from dividends1.221.9961%
Returns for 1 year-1.027.74-13%
Returns for 3 years4.6336.6313%
Returns for 5 years30.7270.1844%
Returns for 10 years30.90131.6423%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHGCF47.064.05
+9.42%
Chugai Pharmaceutical Co., Ltd.
CNGO23.50N/A
N/A
Cengage Learning Holdings II Inc
BYSD0.75N/A
N/A
Bayside Corp.
SHTDF2.42N/A
N/A
Sinopharm Group Co. Ltd.
FCPB11.97N/A
N/A
First Capital Bancshares, Inc.